Subjects: Other Disciplines >> Synthetic discipline submitted time 2023-03-28 Cooperative journals: 《中国科学院院刊》
Abstract: In 1995, the Committee on Typical Culture Collection of Chinese Academy of Sciences (CAS) was established and renamed as the Committee on Biological Genetic Resource Banks of CAS in 2015. Under the Committee there are 12 members of bio-resource bank from 11 institutes of CAS. Bio-resources like seeds, plant tissue in vitro, human cell lines and stem cells, animal cells and tissue samples, microorganisms, microalga, and seaweeds are collected and deposited in the banks of Committee. Each year about 40000–50000 cultures were shared. The basic orientation, composition, and bio-resource scale of the Biological Genetic Resource Bank of CAS, and its supporting role in scientific research, major national needs and national economy are introduced in the paper. Based on the trend of the collection and sustainable utilization of bio-genetic resources, the key works of bio-resources are proposed.
Subjects: Biology >> Biomedical Laboratory Science submitted time 2017-07-03
Abstract:由于生物医药产业具有相当可观的经济和社会效益,其已经成为许多国家重点发展的朝阳产业。为推动生物医药相关产业的发展,诸如美国、日本、印度等国家把生物技术产业作为了提高本国竞争力的手段,并制定了相应的法律法规规范生物医药产业的发展和保障生物医药的知识产权。本论文首先从宏观层面进行各角度数据分析,包括全球、我国的生物医药产业知识产权发展态势分析,然后以广东省生物医药产业为例,对其知识产权密集型情况指标的数据进行分析,并与其他省份的产业经济和专利情况等指标数据进行对比,最后提出有效提高广东省生物医药产业发展和运用知识产权,增强产业竞争力的对策和建议。
Peer Review Status:Awaiting Review
Subjects: Biology >> Biomedical Laboratory Science submitted time 2017-05-23
Abstract:摘要:知识产权密集型产业具备较为明显的专利优势,依赖技术创新与知识产权参与市场摘要:知识产权密集型产业具备较为明显的专利优势,依赖技术创新与知识产权参与市场竞争。生物医药产业具有巨大的经济效益和社会效益,是广东大力扶持的新兴产业。本文选取广东高技术产业、先进制造业及传统产业下的若干产业与生物医药产业进行知识产权密集型情况对比,并通过发展现状、经济贡献及研发创新三个维度进行了对比,最后利用SPSS工具对广东省生物医药专利发展进行预测,为增强广东生物医药知识产权密集型产业竞争力提供建议。
Peer Review Status:Awaiting Review
Subjects: Biology >> Biomedical Laboratory Science submitted time 2017-03-08
Abstract:[摘 要] 生物医药产业已经成为继信息产业之后全球经济社会发展的又一重要[摘 要] 生物医药产业已经成为继信息产业之后全球经济社会发展的又一重要推动力,而各类型科技创新平台已经成为生物医药产业发展的重要支撑。本文通过对广州市生物医药领域各类型科技创新平台的深入调查与分析,理清了各平台建设、运营和服务的基本情况;并对比国内外相关发展情况,找出了广州市生物医药领域科技创新平台服务存在的问题;提出了如推进生物医药战略性新兴领域的国家实验室建设、牵头建设珠三角生物医药共享平台等具有针对性的对策与参考意见。
Peer Review Status:Awaiting Review